StockGuru Trade Alert: Newest Profile Signature Leisure, Inc. (OTCBB: SGLS) is Up Over 21% in Early Trading
StockGuru Trade Alert: Newest Profile Signature Leisure, Inc. (OTCBB: SGLS) is Up Over 21% in Early Trading StockGuru just Announced…
Blog
StockGuru Blog: Sports Pouch Beverage Company, Inc. (OTC: SPBV)
Some Marriages are PERFECT! Sports Pouch Beverage Company, Inc. Aligns Itself with Fastest Growing Niche in Beverage Industry Stock Guru…
StockGuru Welcomes Signature Leisure, Inc. (OTCBB: SGLS)
Signature Leisure, Inc. (OTCBB: SGLS) Signature Leisure, Inc. (OTCBB: SGLS) provides investor relations (”IR”) services to publicly traded companies. The…
StockGuru Welcomes Sports Pouch Beverage Company, Inc. (OTC: SPBV)
Sports Pouch Beverage Company, Inc. (OTC: SPBV) Sports Pouch Beverage Company, Inc. (OTC: SPBV) was established for the specific purpose…
Modavox, Inc. (MDVX.OB) is Scheduled to Present at The RedChip Conference Today at Noon
Modavox invites the entire investment community to view its presentation at the RedChip Conference in San Fransisco today at 12…
Beacon Equity Research Rates American Food Co., Inc (AFHD.PK) with a $0.40 Target Price
American Food Company manufactures and markets snack foods under the “Reinhold & Timko Beef Snacks” brand name, and supplies their…
HealthSport Announces Dr. C.T. Moorman as Sports Advisory Council Chairman Duke Physician to lead council of athletes, trainers, and medical professionals
HealthSport, Inc. (OTCBB: HSPO), announced the appointment of Duke University’s C.T. Moorman, M.D. as the Chairman of the newly formed…
SSPE Gets Help from Nike & Creates “Art of War”
SUN Sports & Entertainment Inc. (Pink Sheets: SSPE) announced that it has completed the formation of MMA Games LLC with…
A Leading Financial Website Released a Comprehensive Profile on Novori Inc. (NOVO.OB)
Shazamstocks announced that they have finished a complete profile on Novori. In the profile they complimented Novori for being the fastest growing company…
AMAR Focused on Phase II Completion During Q1
Amarillo Biosciences Inc. (OTCBB: AMAR) had a busy first quarter focusing on its goal of completing Phase II clinical trials…